|
000
| 01915nam 2200325za 4500 |
|---|
| 001 | 9.824608 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107144150 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160922s2016 onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-9/2016-25E-PDF |
|---|
| 245 | 00|aAzamethiphos |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bHealth Canada, |cc2016. |
|---|
| 300 | |a64 p. |
|---|
| 490 | 1 |aProposed registration decision, |x1925-0886 ; |vPRD2016-25 |
|---|
| 500 | |aIssued also in French under title: Azaméthiphos. |
|---|
| 500 | |a"20 September 2016.” |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of Azamethiphos Technical and Salmosan Vet containing the technical grade active ingredient azamethiphos, to control sea lice on Atlantic salmon. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of Azamethiphos Technical and Salmosan Vet"--Overview. |
|---|
| 530 | |aIssued also in printed form. |
|---|
| 692 | 07|2gccst|aPesticides |
|---|
| 692 | 07|2gccst|aCertification |
|---|
| 692 | 07|2gccst|aToxicology |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 710 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 775 | 08|tAzaméthiphos |w(CaOODSP)9.824610 |
|---|
| 830 | #0|aProposed registration decision,|x1925-0886 ; |vPRD2016-25|w(CaOODSP)9.504464 |
|---|
| 856 | 40|qPDF|s678 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H113-9-2016-25-eng.pdf |
|---|